231 Ces Urol 2022; 26(4): 224–231 PŘEHLEDOVÝ ČLÁNEK 25. Flaifel A, Guzzetta M, Occidental M, et al. Testicular Changes AssociatedWith Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‑CoV-2). Archives of Pathology & Laboratory Medicine. 2020; 145(1): 8–9. 26. Li H, Xiao X, Zhang J, et al. Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. 2020; 28: 100604. 27. Xu J, Qi L, Chi X, et al. Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1. Biology of Reproduction. 2006; 74(2): 410–416. 28. Pan F, Xiao X, Guo J, et al. No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020; 113(6): 1135–1139. 29. Moghimi N, Eslami Farsani B, Ghadipasha M, et al. COVID-19 disrupts spermatogenesis through the oxidative stress pathway following induction of apoptosis. Apoptosis. 2021; 26(7): 415–430. 30. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology. 2020; 20(6): 363–374. 31. Ediz C, Tavukcu HH, Akan S, et al. Is there any association of COVID-19 with testicular pain and epididymo ‑orchitis? International Journal of Clinical Practice. 2021; 75(3): e13753. 32. Qingqing C, Wen QH, Ming Z, Huijun L, Zhen FF. Enhancement of Blood‑Brain Barrier Permeability and Reduction of Tight Junction Protein Expression Are Modulated by Chemokines/Cytokines Induced by Rabies Virus Infection. Journal of Virology. 2014; 88(9): 4698–4710. 33. Vishvkarma R, Rajender S. Could SARS‑CoV-2 affect male fertility? Andrologia. 2020; 52(9): e13712–e13712. 34. Ma L, Xie W, Li D, et al. Evaluation of sex‑related hormones and semen characteristics in reproductive ‑aged male COVID-19 patients. Journal of Medical Virology. 2021; 93(1): 456–462. 35. Ma L, XieW, Li D, et al. Effect of SARS‑CoV-2 infection uponmale gonadal function: a single center‑based study. medRxiv. 2020. 36. Tian Y, Zhou L quan. Evaluating the impact of COVID-19 on male reproduction. Reproduction. 2021; 161(2): 37–44. 37. Pazir Y, Eroglu T, Kose A, et al. Impaired semen parameters in patients with confirmed SARS‑CoV-2 in‑ fection: A prospective cohort study. Andrologia. 2021; 53(9): e14157. 38. Collodel G, Capitani S, Pammolli A, et al. Semen Quality of Male Idiopathic Infertile Smokers and Non‑ smokers: An Ultrastructural Study. Journal of Andrology. 2010; 31(2): 108–113. 39. World Health Organization, editor. WHO laboratory manual for the examination and processing of human semen. 6th ed. Geneva, Switzerland; 2021. 40. Guo L, Zhao S, Li W, et al. Absence of SARS‑CoV-2 in semen of a COVID-19 patient cohort. Andrology. 2021; 9(1): 42–47. 41. Song H, Seddighzadeh B, Cooperberg MR, Huang FW. Expression of ACE2, the SARS‑CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells. Eur Urol. 2020; 78(2): 296–298. 42. Massarotti C, Garolla A, Maccarini E, et al. SARS-CoV-2 in the semen: Where does it come from? Andro‑ logy. 2021; 9(1): 39–41. 43. Wang Z, Xu X. scRNA‑seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS‑CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells. 2020; 9(4): 920. 44. Aitken RJ. COVID-19 and male infertility: An update. Andrology. 2022.
RkJQdWJsaXNoZXIy NDA4Mjc=